Achieving Process Understanding and Control in Film Coating - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Achieving Process Understanding and Control in Film Coating
The authors describe a QbD study that was performed to optimize a coating system.


Pharmaceutical Technology
Volume 36, Issue 9, pp. s18-s21

Color quality


Table III: Target colorimetry values (Spectrablend II Pink, Sensient Pharmaceutical Coating Systems).
Colorimetry was used to measure the color shade. The L* value is the white/black color space. The a* value is the red/green space, and the b* value is the blue/yellow space. Target L*, a*, and b* values are listed in Table III. The total color difference (ΔE*) is calculated from the differences between L*, a*, and b* values and the target by taking the square root of the sum of differences squared. Specifications for L*, a*, and b* values were defined based on ΔE* < 2.0.


Figure 1: Pareto chart of the standardized effects of the experimental variables on the L* value, which describes the white/black color space, Alpha = 0.10. (ALL FIGURES ARE COURTESY OF THE AUTHORS)
All 450 samples were analyzed by regression to detect the factors that had a significant L* value. The data analysis revealed that all six factors (i.e., level of titanium dioxide, red dye, and MCT in the coating system, and percentage of weight gain, coating exhaust temperature, and spray rate) had significant effect on the L* value. The regression model had a R2 (adjusted) of 92.10% and a lack-of-fit p-value of 0.000. The relative effect of the variables is shown in Figure 1. The data analysis revealed that TiO2 and red dye had the most significant effect; both exhaust temperature and spray rate also had a significant effect on L*.


Figure 2: Pareto chart of the standardized effects of the experimental variables on the a* value, which describes the red/green color space, Alpha = 0.10.
A similar regression analysis was performed to identify the factors that may have significant effect on the a* value. The data analysis revealed that the same six factors had significant effect on the a* value. The regression model had a R2 (adjusted) of 91.57% and a lack-of-fit p-value of 0.000. The relative effect of the variables is shown in Figure 2. The data analysis revealed that the levels of TiO2 and red dye had the most significant effect; both exhaust temperature and spray rate also had significant effect on the a* value.


Figure 3: Pareto chart of the standardized effects of the experimental variables on the b* value, which describes the blue/yellow color space, Alpha = 0.10.
Lastly, a similar regression analysis was performed to identify the factors that may have a significant effect on the b* value. The data analysis revealed only four factors (i.e., TiO2 and red dye levels, percentage of weight gain, and coating exhaust temperature) had significant effect on the b* value. The regression model had a R2 (adjusted) of 86.6% and the lack-of-fit p-value of 0.000. The relative effect of the variables is shown in Figure 3. The data analysis revealed that TiO2 and red dye levels had the most significant effect; both exhaust temperature and spray rate also had a significant effect on b* value.


Figure 4: Contour plot of calorimetry measurements (L*, a*, and b* values) in relation to red dye and titanium dioxide concentrations in the formulation. Variables held constant were weight gain (3%), medium chain triglyceride concentration (7.0%), exhaust temperature (40 °C), and spray rate (10 g/min).
An optimization of the factors targeted for the L*, a*, and b* value was calculated using multiregressional analysis. Optimal material and process factors are highlighted in red in Figure 4, which shows that the colorant level had a larger effect on color shade compared with the process effects (e.g., exhaust temperature and spray rate). For the optimized solution at 3% weight gain, the predicted L*, a*, and b* values were 75.86, 32.21, and 9.07, respectively. The predicted ΔE* was 0.0, which is a perfect match. A process specification of the TiO2 and red dye was also calculated based on the lower and upper percentage limits of both ingredients. The white area of the plot in Figure 4 is the allowable level of the color ingredient that would meet ΔE* < 2.0. A different color specification can be determined by using the same design space.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here